Skip to main content
Clinical Trials/NL-OMON47931
NL-OMON47931
Recruiting
Not Applicable

Platelet RNA profiling to screen for cancer in patients with unprovoked venous thromboembolism - Tumour-educated platelets in venous thromboembolism

Academisch Medisch Centrum0 sites270 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
venous thromboembolism
Sponsor
Academisch Medisch Centrum
Enrollment
270
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- First, objectively confirmed, symptomatic, unprovoked symptomatic pulmonary
  • embolism and/or distal or proximal deep vein thrombosis of the leg
  • \- Age 40 years or older
  • \- Written informed consent

Exclusion Criteria

  • \- One or more of the following risk factors for veneuze trombo\-embolie (VTE):
  • \- known malignant disease prior to VTE defined as a cancer diagnosis or
  • cancer treatment within the past 5 years;
  • \- trauma or fracture of the leg, surgical procedures, general anesthesia, or
  • immobilization greater than 3 days within previous 3 months;
  • \- previous unprovoked venous thromboembolism;
  • \- known hereditary or acquired thrombophilia;
  • \- current pregnancy or puerperium (up to 3 months postpartum);
  • \- current estrogen therapy.
  • \- Greater than 10 days after VTE diagnosis;

Outcomes

Primary Outcomes

Not specified

Similar Trials